Skip to main content
OpenTrials
Completed

NCT Number: NCT04505657

Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography

our aims to investigate the effectiveness of10% Lidocaine Spray plus oral celecoxib for Pain Control During Hysterosalpingography

Completed

Looking for future studies?

Notify Me

Key information

Conditions

IUCD Complication

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Aswan University Hospital

Aswān, 81528, Egypt

About this study

hysterosalpingography can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the cannula; and injection of the dye

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • any patient came for Hysterosalpingography

Exclusion criteria

  • any patient has contraindication to Hysterosalpingography

Treatment and study plan

celecoxib plus lidocaine

Drug

Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure

Other names: experimental

Celecoxib

Drug

Celecoxib 200 mg (Celebrex® 200, Pfizer,USA) administered orally 2 h before the procedure +Sterile water 4 puffs during the procedure

Other names: Active Comparator

Lidocaine

Drug

placebo to celecoxib administered orally 2 h before the procedure +10% lidocaine spray 4 puffs during the procedure

Other names: Active Comparato

Primary outcomes

  1. Mean pain score during the procedure

    Time frame: 10 minuets

    Assessment of pain using visual analog scale 0-10, 0 = minimum and 10 = maximum scores

Sponsors and collaborators

Lead sponsor

Aswan University Hospital

Other

Registry information

Official study title

Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography: a Randomized Controlled Trial

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Aug 10, 2020
Registry last updated
Sep 29, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.